Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis. (Q48547710)

12 February 2018

title

Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis. (English)

1 reference

12 February 2018

0 references

0 references

1

1 reference

12 February 2018

Margherita Fanelli

3

1 reference

12 February 2018

Paolo Livrea

6

1 reference

12 February 2018

Maria Trojano

object named as

M Trojano

2

0 references

author name string

C Avolio

4

1 reference

12 February 2018

A Fasano

5

1 reference

12 February 2018

P Riccio

7

1 reference

12 February 2018

publication date

1 May 2002

1 reference

12 February 2018

Multiple Sclerosis Journal

published in

1 reference

12 February 2018

volume

8

1 reference

12 February 2018

page(s)

222-228

1 reference

12 February 2018

issue

3

1 reference

12 February 2018

Matrix metalloproteinase degradation of extracellular matrix: biological consequences

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS800OA

The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS800OA

The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS800OA

Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS800OA

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS800OA

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS800OA

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS800OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS800OA

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS800OA

Cytokine-regulated proteases in autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS800OA

Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS800OA

Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS800OA

Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS800OA

Processing of tumour necrosis factor-α precursor by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS800OA

10.1191/1352458502MS800OA

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

12120694

1 reference

12 February 2018